AKAFTREO Trademark

Trademark Overview

On Thursday, March 29, 2018, a trademark application was filed for AKAFTREO with the United States Patent and Trademark Office. The USPTO has given the AKAFTREO trademark a serial number of 87855144. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 22, 2021. This trademark is owned by Vertex Pharmaceuticals Incorporated. The AKAFTREO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cystic fibrosis
akaftreo

General Information

Serial Number87855144
Word MarkAKAFTREO
Filing DateThursday, March 29, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 22, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cystic fibrosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 5, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, November 22, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 22, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 30, 2021SOU EXTENSION 5 GRANTED
Friday, April 16, 2021SOU EXTENSION 5 FILED
Friday, April 30, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 16, 2021TEAS EXTENSION RECEIVED
Saturday, October 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 15, 2020SOU EXTENSION 4 GRANTED
Thursday, October 15, 2020SOU EXTENSION 4 FILED
Thursday, October 15, 2020TEAS EXTENSION RECEIVED
Sunday, June 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, June 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2020SOU EXTENSION 3 GRANTED
Wednesday, April 8, 2020SOU EXTENSION 3 FILED
Wednesday, April 8, 2020TEAS EXTENSION RECEIVED
Friday, October 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2019SOU EXTENSION 2 GRANTED
Wednesday, October 16, 2019SOU EXTENSION 2 FILED
Wednesday, October 16, 2019TEAS EXTENSION RECEIVED
Wednesday, April 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 15, 2019SOU EXTENSION 1 GRANTED
Monday, April 15, 2019SOU EXTENSION 1 FILED
Monday, April 15, 2019TEAS EXTENSION RECEIVED
Tuesday, October 16, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 17, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 16, 2018ASSIGNED TO EXAMINER
Thursday, April 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 2, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

akaftreo fibrosis cystic treatment preparations pharmaceutical